https://www.businesswire.com/news/home/20260328338918/en/EVTL-Investors-Have-Opportunity-to-Join-Vertical-Aerospace-Ltd.-Fraud-Investigation-with-the-Schall-Law-Firm 2026-03-28T23:19:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328721653/en/SAN-Investors-Have-Opportunity-to-Join-Banco-Santander-S.A.-Fraud-Investigation-with-the-Schall-Law-Firm 2026-03-28T21:44:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328916391/en/BW-Investors-Have-Opportunity-to-Join-Babcock-Wilcox-Enterprises-Inc.-Fraud-Investigation-with-the-Schall-Law-Firm 2026-03-28T21:21:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328084287/en/Kardigan-Announces-Positive-Phase-2-Data-for-Tonlamarsen-in-Patients-with-Uncontrolled-Hypertension-Presented-as-Late-Breaker-at-ACC.26-and-Simultaneously-Published-in-JACC 2026-03-28T20:45:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328410580/en/Debevoise-Secures-Second-Circuit-Affirmance-of-Dismissal-of-%2416-billion-Claim-Against-YPF-S.A. 2026-03-28T20:18:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328961027/en/YRD-Investors-Have-Opportunity-to-Join-Yiren-Digital-Ltd.-Fraud-Investigation-with-the-Schall-Law-Firm 2026-03-28T19:47:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328356604/en/PODD-Investors-Have-Opportunity-to-Join-Insulet-Corporation-Fraud-Investigation-with-the-Schall-Law-Firm 2026-03-28T19:27:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328305951/en/PRTH-Investors-Have-the-Opportunity-to-Join-Investigation-of-Priority-Technology-Holdings-Inc.-with-the-Schall-Law-Firm 2026-03-28T19:02:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328441699/en/Incyte-Announces-New-Positive-54-Week-Late-Breaking-Data-for-Povorcitinib-in-Hidradenitis-Suppurativa-at-the-2026-American-Academy-of-Dermatology-AAD-Annual-Meeting 2026-03-28T19:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328412417/ja 2026-03-28T19:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328889059/en/Takedas-Zasocitinib-Delivered-Rapid-and-Durable-Skin-Clearance-in-a-Convenient-Once-Daily-Pill-Affirming-Promise-to-Reshape-Psoriasis-Care 2026-03-28T19:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328971109/en/Corcept-Presents-Data-from-MOMENTUM-Trial-at-American-College-of-Cardiology-Annual-Scientific-Session 2026-03-28T18:45:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328320362/en/AAD-2026-Late-Breaking-Nemolizumab-Data-Demonstrate-Clinically-Meaningful-Benefits-for-Children-Aged-2-to-11-With-Moderate-to-Severe-Atopic-Dermatitis 2026-03-28T15:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260327181824/en/Anumana-Secures-FDA-Clearance-for-First-of-Its-Kind-ECG-AI-Algorithm-for-Early-Detection-of-Pulmonary-Hypertension 2026-03-28T14:48:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328205340/en/Arrowhead-Pharmaceuticals-Presents-New-Long-Term-Efficacy-and-Safety-Data-for-Plozasiran-Across-a-Spectrum-of-Hypertriglyceridemia-at-the-American-College-of-Cardiologys-75th-Annual-Scientific-Session-and-Expo 2026-03-28T14:30:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328508442/en/IBRX-INVESTOR-ALERT-Robbins-Geller-Rudman-Dowd-LLP-Announces-that-ImmunityBio-Inc.-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit 2026-03-28T14:15:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260328341048/en/Visa-Street-Soccer-USA-and-Bank-of-America-to-Bring-Visa-Street-Soccer-Parks-to-Every-FIFA-World-Cup-2026-Host-City-in-the-U.S. 2026-03-28T11:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260326860298/en/Open-Label-Outpatient-Switch-Study-Demonstrates-Symptom-Stability-During-Transition-from-Oral-Atypical-Antipsychotics-to-Cobenfy-xanomeline-and-trospium-chloride 2026-03-28T11:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260327014418/en/Nicklaus-Companies-LLC-Closes-Sale-of-Business-to-Jack-Nicklaus-Backed-20-Majors-LLC 2026-03-28T01:23:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260327774630/zh-HK 2026-03-28T00:37:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260327761376/zh-CN 2026-03-28T00:36:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260327189267/zh-HK 2026-03-28T00:24:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260327807517/zh-CN 2026-03-28T00:24:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260327492704/en/ADMA-BIOLOGICS-INC.-INVESTIGATION-Kirby-McInerney-LLP-Announces-Investigation-Into-Potential-Securities-Fraud 2026-03-28T00:00:00.000Z weekly 0.5